187 related articles for article (PubMed ID: 37871205)
1. Activity-induced MeCP2 phosphorylation regulates retinogeniculate synapse refinement.
Tzeng CP; Whitwam T; Boxer LD; Li E; Silberfeld A; Trowbridge S; Mei K; Lin C; Shamah R; Griffith EC; Renthal W; Chen C; Greenberg ME
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310344120. PubMed ID: 37871205
[TBL] [Abstract][Full Text] [Related]
2. Activity-Induced MeCP2 Phosphorylation Regulates Retinogeniculate Synapse Refinement.
Tzeng CP; Whitwam T; Boxer LD; Li E; Silberfeld A; Trowbridge S; Mei K; Lin C; Shamah R; Griffith EC; Renthal W; Chen C; Greenberg ME
bioRxiv; 2023 Jul; ():. PubMed ID: 37461668
[TBL] [Abstract][Full Text] [Related]
3. Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice.
Noutel J; Hong YK; Leu B; Kang E; Chen C
Neuron; 2011 Apr; 70(1):35-42. PubMed ID: 21482354
[TBL] [Abstract][Full Text] [Related]
4. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.
Ebert DH; Gabel HW; Robinson ND; Kastan NR; Hu LS; Cohen S; Navarro AJ; Lyst MJ; Ekiert R; Bird AP; Greenberg ME
Nature; 2013 Jul; 499(7458):341-5. PubMed ID: 23770587
[TBL] [Abstract][Full Text] [Related]
5. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
6. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function.
Cohen S; Gabel HW; Hemberg M; Hutchinson AN; Sadacca LA; Ebert DH; Harmin DA; Greenberg RS; Verdine VK; Zhou Z; Wetsel WC; West AE; Greenberg ME
Neuron; 2011 Oct; 72(1):72-85. PubMed ID: 21982370
[TBL] [Abstract][Full Text] [Related]
8. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
9. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.
Nguyen MV; Du F; Felice CA; Shan X; Nigam A; Mandel G; Robinson JK; Ballas N
J Neurosci; 2012 Jul; 32(29):10021-34. PubMed ID: 22815516
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
11. Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression.
Schafer DP; Heller CT; Gunner G; Heller M; Gordon C; Hammond T; Wolf Y; Jung S; Stevens B
Elife; 2016 Jul; 5():. PubMed ID: 27458802
[TBL] [Abstract][Full Text] [Related]
12. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
13. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.
Maezawa I; Jin LW
J Neurosci; 2010 Apr; 30(15):5346-56. PubMed ID: 20392956
[TBL] [Abstract][Full Text] [Related]
14. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
16. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
17. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
18. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.
Lonetti G; Angelucci A; Morando L; Boggio EM; Giustetto M; Pizzorusso T
Biol Psychiatry; 2010 Apr; 67(7):657-65. PubMed ID: 20172507
[TBL] [Abstract][Full Text] [Related]
19. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.
Zhou Z; Hong EJ; Cohen S; Zhao WN; Ho HY; Schmidt L; Chen WG; Lin Y; Savner E; Griffith EC; Hu L; Steen JA; Weitz CJ; Greenberg ME
Neuron; 2006 Oct; 52(2):255-69. PubMed ID: 17046689
[TBL] [Abstract][Full Text] [Related]
20. JNK signaling provides a novel therapeutic target for Rett syndrome.
Musi CA; Castaldo AM; Valsecchi AE; Cimini S; Morello N; Pizzo R; Renieri A; Meloni I; Bonati M; Giustetto M; Borsello T
BMC Biol; 2021 Dec; 19(1):256. PubMed ID: 34911542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
